Understood reports children with ADHD are more likely to struggle with motor skills, highlighting the importance of early ...
Parents of young children with an excitable or exuberant temperament could adapt their parenting style to help moderate their child's potential development of Attention Deficit/Hyperactivity Disorder ...
The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...
Some traits of ADHD that are usually associated with difficulties may also be reflective of a heightened capability to thrive ...
Parents of young children with an excitable or exuberant temperament could adapt their parenting style to help moderate their child's potential development of Attention Deficit/Hyperactivity Disorder ...
The US FDA has accepted for priority review Otsuka Pharmaceutical’s NDA submitted for centanafadine, an investigational, once-daily extended-release capsule for ADHD treatment.
A 17-year longitudinal study from Ben-Gurion University of the Negev followed children from birth to adolescence to explore whether early-life factors can predict ADHD, and for whom the environment ...
ADHD drugs don’t improve attention, new research finds – but they still work - More than seven million U.S. children and 15 million adults adults live with the lifelong brain disorder ...
New brain research could reshape our understanding of ADHD and the most common drugs that treat it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results